Skip to content

Metabolism of Patients With Genetically Caused Cardiac Arrhythmia

Metabolism of Patients With Genetically Caused Cardiac Arrhythmia

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02775513
Enrollment
50
Registered
2016-05-17
Start date
2010-09-30
Completion date
Unknown
Last updated
2016-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long QT Syndrome

Brief summary

Loss-of-function mutations in voltage-gated potassium channels cause long QT syndrome (LQTS) due to a prolonged cardiac repolarisation phase. Hypoteses: patients with loss-of-function mutations also exhibit altered hormone release upon glucose ingestion.

Detailed description

Loss-of-function mutations in voltage-gated potassium channels cause long QT syndrome (LQTS) due to a prolonged cardiac repolarisation phase. Voltage-gated potassium (Kv-) channels are known for their relation to malignant cardiac arrhythmias, but also play a role in pancreatic alpha- and beta cell hormone secretion, and possibly in incretin hormone secretion. We hypothesised that patients with loss-of-function mutations also exhibit altered hormone release upon glucose ingestion.

Interventions

None listed

Sponsors

University of Copenhagen
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

LQTS Gain of function Matched healthy controls

Exclusion criteria

none

Design outcomes

Primary

MeasureTime frameDescription
glucose homeostasis6 hoursmeasured by glucose, insulin, glucagon, GLP-1 and GIP response to glucose (OGTT)

Secondary

MeasureTime frameDescription
QT6 hourscardiac repolarisation

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026